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Third Borrelia
Species in White-
footed Mice 
To the Editor: The white-footed
mouse, Peromyscus leucopus, is a nat-
ural reservoir host of several
pathogens, including Borrelia
burgdorferi, an agent of Lyme borre-
liosis (LB) (1). B. burgdorferi spiro-
chetes are transmitted in the mouse
population by Ixodes scapularis ticks.
This tick vector also bears B. miyamo-
toi, a sister species to the relapsing
fever group of spirochetes (2,3). B.
miyamotoi infects P. leucopus in the
laboratory (2), but the role of this
mouse as a reservoir was not known.
Here we report that P. leucopus is a
reservoir for B. miyamotoi in nature
and, in addition, that this mouse is
host for a third, hitherto unknown,
species of Borrelia. 
In a recent study of a 9-hectare site
in a mixed hardwood forest in eastern
Connecticut, we found that ≈35% of
I. scapularis nymphs were infected
with  B. burgdorferi and  ≈6% were
infected with B. miyamotoi (4). For
that study of a field vaccine we also
collected blood from P. leucopus
mice captured from June to early
September of 2001. DNA was
extracted from the blood and then
subjected to quantitative polymerase
chain reaction (PCR) assay for the
presence of B. burgdorferi as
described (4). In the present study, we
analyzed the extracts of 556 blood
samples from 298 mice from the non-
vaccine control grids by a multiplex,
quantitative real-time PCR for 16S
rDNA that discriminated between B.
burgdorferi and B. miyamotoi at the
site (4). Sixty-nine (12%) of the sam-
ples were positive for B. burgdorferi
and 36 (6%) were positive for B.
miyamotoi; 5 (0.9%) of the samples
were positive for both species. In
infected mice, the mean number of B.
miyamotoi cells per milliliter of blood
was 251 (95% confidence limits of
126–631), 5-fold greater than that of
B. burgdorferi at 50 cells/mL(40–63). 
Astandard PCR assay of the blood
samples with primers for the 16S–23S
rDNA intergenic spacer (IGS) was
performed as described by Bunikis et
al. (5); results suggested the presence
of a third species of Borrelia among
the blood samples of the mice. A
uniquely sized amplicon of ≈350 bp
was observed in the reactions of 6 of
100 samples that were positive for B.
burgdorferi and or B. miyamotoi by
16S PCR, and of 2 of 31 randomly
selected samples that were negative
for both B. burgdorferi and  B.
miyamotoi (p = 0.3 by 2-sided exact
chi-square test). 
Samples with the 350-bp amplicon
were further investigated by PCR
assay with Borrelia  genus-specific
primers for the 16S rRNA gene
(rDNA), as described by Barbour et
al. (6). The resultant ≈830-bp PCR
product from these samples was
directly sequenced on a Beckman
3000CEQ automated sequencer (5).
The 788-bp sequence was aligned
with sequences of other Borrelia
species representing the LB and
relapsing fever clades, and phyloge-
netic analysis was conducted. The
accompanying Figure shows that the
new species clusters with the mono-
phyletic relapsing fever group of
species rather than with the LB group
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Figure. Unrooted maximum-likelihood phylogram for partial 16S rRNA gene sequences of
selected Borrelia species, including a novel Borrelia organism, and representing Lyme
borreliosis and relapsing fever groups. Sequence alignment corresponded to positions
1138 to 1924 of B. burgdorferi rRNA gene cluster (GenBank accession no. U03396).
Maximum likelihood settings for version 4.10b of PAUP* (http://paup.csit.fsu.edu) for
equally weighted characters corresponded to Hasegawa-Kishino-Yano model with an
empirical estimate of transition/transversion ratio = 7. Support for clades was evaluated by
25 bootstrap replications by using branch-and-bound search, and values >50% are indi-
cated along branches. Sequences (with GenBank accession nos.) used in the analysis
were the following: B. andersoni (L46688), B. miyamotoi (D45192), B. lonestari (U23211),
B. hermsii (U42292), B. turicatae (U42299), B. duttonii (U28503), B. anserina (U42284),
and new Borrelia species (AY536513). LETTERS
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species. However, the new spirochete
is distinct from all other known
Borrelia  spp. with an available 16S
rDNA sequence in the GenBank data-
base. Its partial 16S rDNA sequence
differed by 3.3% to 4.2% from 9 LB
group species and 2.4% to 3.4% from
15 relapsing fever group species. For
comparison, intragroup sequence dif-
ferences were <1.9%. On this basis, as
well as the finding of partial IGS
sequences (GenBank accession nos.
AY668955 and AY668956) that were
unique among all Borrelia spp. stud-
ied to date (3,5), we propose that this
is a new species of Borrelia, provi-
sionally named Borrelia davisii in
honor of Gordon E. Davis for his con-
tributions to Borrelia  research and
taxonomy.
While the new species was detect-
ed in 8 of 131 P. leucopus blood sam-
ples by using PCR for the IGS, the
assays for this organism in the DNA
extracts of 282 I. scapularis nymphs
(4) from the same geographic site
were uniformly negative (p = 0.0003,
2-sided Fisher exact test). This find-
ing suggests that the new spirochete
has another vector. The only other
documented tick species that has been
found feeding in small numbers on P.
leucopus  in Connecticut is
Dermacentor variabilis (7). Holden et
al. reported the presence of Borrelia
in D. variabilis ticks in California by
using PCR with genus-specific
primers, but the species in these ticks
was not identified by sequencing (8). 
Although how B. miyamotoi and
B. davisii affect the health of humans
and other animals remain to be deter-
mined, our finding of 3 Borrelia
species with overlapping life cycles in
the same host in the same area shows
that the ecology of Borrelia is more
complex than was imagined. The
presence of species other than B.
burgdorferi in a major reservoir will
have to be considered in future sur-
veys and interventions. 
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Comparing
Diagnostic Coding
and Laboratory
Results
To the Editor: The global
Military Health System maintains
electronic inpatient (Standard
Inpatient Data Record, SIDR) and
outpatient (Standard Ambulatory
Data Record, SADR) clinical diag-
nostic coded data generated by the
Department of Defense Composite
Health Care System (CHCS), an elec-
tronic system that tracks and stores
administrative and other patient
encounter data. Because these
records are readily available, wide-
spread monitoring of these data as a
means of medical surveillance has
been suggested (1,2). Only 1 study in
the literature assessed electronic cod-
ing reliability of these data (3); those
authors found SIDRs to be a reliable
source of billing data for common
diagnoses, not including notifiable
infectious diseases. We compared
SADR and SIDR infectious disease
diagnostic codes to laboratory data to
assess the usefulness of these datasets
in notifiable disease surveillance.
We identified SADRs and SIDRs
coded for malaria, syphilis, acute hep-
atitis B, and Lyme disease in sailors,
marines, and their family members,
who were beneficiaries for medical
care in a large metropolitan area.
Medical encounters from January 1,
2001, to June 30, 2002, were studied.
All records for the same patient with
the same diagnostic code(s) were con-
sidered as 1 encounter. Records were